@article{Cortese_S-2020_6655,
title = {ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group},
author = {Cortese, S. and Asherson, P. and Sonuga-Barke, E. and Banaschewski, T. and Brandeis, D. and Buitelaar, J. and Coghill, D. and Daley, D. and Danckaerts, M. and Dittmann, R. and Doepfner, M. and Ferrin, M. and Hollis, C. and Holtmann, M. and Konofal, E. and Lecendreux, M. and Santosh, P. and Rothenberger, A. and Soutullo, C. and Steinhausen, H. and Taylor, E. and Van der Oord, S. and Wong, I. and Zuddas, A. and Simonoff, E.},
month = {jun},
year = {2020},
abstract = {The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians on how best to deliver care within the new restrictions. Therefore, the European ADHD Guidelines Group (EAGG) has developed guidance on the assessment and management of ADHD during the COVID-19 virus pandemic.},
pages = {412-414},
volume = {4},
issue = {6},
journal = {The Lancet Child & Adolescent Health},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2352-4642(20)30110-3},
}
